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Dear Editor,
Nasal septum perforation (NSP) is a potential compli-
cation of septorhinoplasty that should be considered a risk
for the surgical procedure. However, NSP may have other
causes such as trauma, infection, degeneration, overuse
of vasoconstrictors, abuse of cocaine, and chemotherapy
agents. Nowadays, NSP is increasing due to increases in
septorhinoplasty (1, 2). Many surgical procedures have
been proposed to repair the defect either by endonasal
approaches using mucoperichondrial flaps or combined
flaps such as interpositional grafts using septal cartilages,
middle turbinate flaps, auricular or costal cartilage, and
temporal fascia or using other non-autologous tissues and
synthetic materials (3-5).
In recent years, acellular dermal allograft has been
used as a graft material in NSP, eliminating the need for
autogenous materials. The acellular dermal allograft can
be used with other flaps such as inferior turbinate flaps,
with different success rates, and is processed by human
donor skin from approved tissue banks. The epidermis is
removed, and the rest of the dermal layer is washed with
detergent and antiviral solutions to remove cellular com-
ponents (6-8). This study aimed to describe the use of Allo-
Derm for the repair of NSP without any other flap, its suc-
cess rate, and the possibility of growth over AlloDerm.
In this study, seven patients, including two females and
five males with a median age of 48 years (range 32 to 65
years) underwent the AlloDerm graft procedure in the ENT
Department of Rasoul Akram during 2013 - 2015. The re-
search followed the tenets of the Declaration of Helsinki.
Written informed consent was obtained, and the patients
were free to leave the study at any time. All patients had
symptomatic anterior septal perforation ranging from 0.5
to 2.5 cm. None of the patients had ever been diagnosed
with substance abuse and had no previous medical condi-
tions. The main etiology for NSP was a previous surgery of
the nasal septum, and only two of them had a history of
digital trauma. The major symptom was a feeling of nasal
obstruction. The procedure was done in open septorhino-
plasty incision in two patients who had a nasal deformity
and required revision rhinoplasty. Other patients under-
went close septoplasty in a conventional pattern, and the
mucoperichondrial flap was elevated with hemitransfixa-
tion incision. The edges of the perforation were debrided,
and the mucoperichondrial flaps were raised around the
margin of the perforation. A zero-degree endoscope was
used for superior and posterior borders to fresh n perfo-
ration more than 1.5 centimeters (Figure 1). The allograft
was rehydrated by soaking in saline for 10 min and then
trimmed to the appropriate size. Then, it was positioned
beneath the edge of perforation and secured in place with
Vicryl suture an internal splint. At least 1 cm of AlloDerm
was overlapped with mucosa.
The internal splint was removed after about four weeks
with a septum examination by an endoscope. It is worth
mentioning that two patients with a previous history of
rhinoplasty, who complained of tip ptosis in one and sad-
dle dorsum in the other, underwent open rhinoplasty ap-
proach to correct this problem. One of them (case F1) had a
history of open septorhinoplasty 15 years ago, and NSP had
been repaired with a titanium mesh six years ago. No mu-
coperichondrium was observed over the titanium mesh,
and it was full of crusting. The chief complaint of the pa-
tient was malodor breathing. The mesh was removed and
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Figure 1. Measurement of perforation size in a patient with a history of rhinoplasty
surgery
replaced with AlloDerm. Additionally, interdomain suture
was used to retrieve tip ptosis. In the other patient (case
F2) who had a history of open septorhinoplasty five years
ago with a chief complaint of saddle nose deformity, Al-
loDerm was used for dorsal augmentation and nasoseptal
deformity correction.
Totally, seven patients underwent the NSP repairing
surgery using AlloDerm grafts and only two patients with
small perforation (< 1 cm) were cured completely. In these
two patients, only the mucosa grew around the perfora-
tion edges (2 mm). In two patients who underwent revi-
sion rhinoplasty, the overall outcome was satisfying after
the improvement of ptosis and dorsum although no im-
provement in NSP was achieved (Table 1).
Despite great advances in the field of septorhinoplasty,
the treatment of NSP is still a challenging issue. Various
methods have been recommended for surgery, including
advancement flaps, local flaps, and external materials such
as titanium mesh or AlloDerm, with different degrees of
success (3-5, 9). The success of these methods depends on
several factors including the perforation size, the experi-
ence of the surgeon, primary cause, postoperative care,
and underlying disease (1, 10). Acellular dermal allograft
has been used since 1992 as a dermal replacement graft for
patients with burning. It has been used as an interposi-
tional graft after experimental evidence that it acts as an
excellent scaffold for reepithelialization of cutaneous and
mucosal surfaces (6, 7). Acellular dermal allograft has sev-
eral advantages, including the elimination of donor site
morbidity, availability in quantities sufficient for all perfo-
ration sizes, and simplicity. Kridel et al. (6), in 1998 for the
first time, described the use of AlloDerm as an interposi-
tional graft in NSP in 12 patients. Eleven out of 12 patients
had successful outcomes with complete closure of perfora-
tion. Friedman et al. in 2003 described a closed endoscopic
repair technique to develop an inferior turbinate flap with
AlloDerm as an interpositional graft (11). The successful clo-
sure rate was 76.5% with perforations ranging from 1 cm to
2.5 cm using a unilateral intranasal mucosal flap in most
of the patients. Studies on the use of AlloDerm without ad-
vancement flap or local flap have been rarely considered
(2). In our study, the effectiveness of AlloDerm for the re-
construction of septum depends on the perforation size.
In this way, the perforations that were less than 1 cm with-
out a history of previous surgery were closed completely,
while graft failure was observed in large perforations and
damaged mucosa.
Previous studies used AlloDerm as supporting mate-
rial for local or advancement flaps. However, we used Al-
loDerm as a scaffold flap for mucosal growth. We realized
that it can be enough for small perforation, while for larger
ones, it cannot be used, and other flaps should be simul-
taneously used for mucosal growth. However, it is essen-
tial to conduct future studies with larger sample sizes for
obtaining information regarding all possibilities for more
specific results and final decision.
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Table 1. The Outcome of the Study Alongside Etiologies
Code Sex Age Etiology Size Outcome
1 F 52 Septorhinoplasty 2.3 × 2.2 Graft failure
2 F 32 Septorhinoplasty 1.8 × 1.5 Graft failure
3 M 33 Septoplasty 2.5 × 2 Initial success, then 2-mm perforation at two months
4 M 42 Digital trauma 0.5 × 0.6 Success
5 M 61 Septoplasty 1.2 × 1.3 Initial success, then 2-mm perforation at two months
6 M 65 Septoplasty 2.5 × 2 Graft failure
7 M 55 Digital trauma 0.5 × 0.3 Success
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